Related Experiment Video
Updated: Jul 10, 2026
A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells
Published on: July 31, 2012
Cloning, expression and purification of human epidermal growth factor using different expression systems
L Ferrer Soler1, J Cedano, E Querol
1Unitat de Bioquímica, Departament de Biologia, Facultat de Ciències, Universitat de Girona, Campus de Montilivi, Spain.
Abstract:
Epidermal growth factor (EGF) is a protein that belongs to the family of growth factors that bind the ErbB receptors, which play a prominent role in the development of carcinomas. We had demonstrated that potato carboxypeptidase inhibitor (PCI) acts as an EGF antagonist. Because of the low affinity of PCI for the epidermal growth factor receptor, it was decided to design EGF mutants with PCI abilities. In order to achieve this we have first cloned, expressed and purified the native protein, EGF. Different expression systems with different locations of the recombinant protein were designed and a purification protocol was designed with those which allowed expression of EGF. Finally, the sample needed folding. Differences in the amount of EGF obtained and its activity were observed depending on the expression system used.
Insights
Researchers engineered epidermal growth factor (EGF) mutants to improve binding affinity. This study focused on creating novel EGF variants with enhanced therapeutic potential for carcinoma treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Epidermal growth factor (EGF) is crucial in cell signaling and implicated in carcinoma development.
- Potato carboxypeptidase inhibitor (PCI) exhibits EGF antagonist properties.
- The low affinity of PCI for the EGF receptor necessitates the development of improved antagonists.
Purpose of the Study:
- To design and produce EGF mutants with enhanced PCI-like inhibitory abilities.
- To investigate the impact of different expression systems on EGF production and activity.
- To establish a purification and refolding protocol for recombinant EGF.
Main Methods:
- Cloning and expression of native EGF using various systems.
- Development of a purification protocol for recombinant EGF.
- Refolding of purified EGF samples.
Main Results:
- Successful cloning, expression, and purification of native EGF.
- Variations in EGF yield and activity were observed across different expression systems.
- A functional refolding protocol was established for the purified protein.
Conclusions:
- The study successfully produced native EGF, laying the groundwork for developing EGF mutants.
- Expression system choice significantly impacts EGF yield and biological activity.
- Engineered EGF variants hold promise for developing novel carcinoma therapeutics.
More Related Videos
07:08Efficient Mammalian Cell Expression and Single-step Purification of Extracellular Glycoproteins for Crystallization
Published on: December 23, 2015
11:42High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension
Published on: December 28, 2015